NA

Healthcare · Pharmaceuticals

Natural Capsules Ltd (NATCAPSUQ)

₹126.19

Mkt cap
₹132 Cr
P/E ratio
—
P/B
0.60
Div yield
0.00%
ROE
−9.45%
ROCE
−4.58%
EPS (TTM)
—
Book value
₹209
52W range
126–234
Sector
Healthcare

Price history

Previous close

Incorporated in 1993, Natural Capsules manufactures Capsules and Steroidal APIs and their Intermediates and Derivatives [1]

NSE NATCAPSUQBSE 524654
Health check
Cautious
ProfitabilityWeak
GrowthModerate
TechnicalsBearish
52-week range
−46.07% from high
₹126
₹1260.00% from low₹234
Current
₹126.19
Prev close
₹132.83
Day
−5.00%
Price performance
1D
−5.00%
1W
−17.05%
1M
−16.06%
3M
−16.65%
6M
−16.83%
1Y
−38.10%
YTD
−36.16%

Financials

Revenue, profit & margin
 Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Trend
Sales37.5239.9840.2239.1841.2243.8344.9745.2045.8037.7558.4548.7151.15
YoY Sales growth-16.73%-12.13%+6.91%+3.93%+9.86%+9.63%+11.81%+15.36%+11.11%-13.87%+29.98%+7.77%+11.68%
Expenses32.4035.2636.1134.8136.7239.5640.5844.8846.6940.0757.1247.5948.14
Operating Profit5.124.724.114.374.504.274.390.32-0.89-2.321.331.123.01
OPM %13.65%11.81%10.22%11.15%10.92%9.74%9.76%0.71%-1.94%-6.15%2.28%2.30%5.88%
Other Income0.350.500.920.180.110.110.300.360.160.450.760.170.19
Interest1.161.241.401.491.651.541.642.532.682.852.892.792.91
Depreciation2.172.192.202.282.352.332.164.214.294.364.284.334.87
Profit before tax2.141.791.430.780.610.510.89-6.06-7.70-9.08-5.08-5.83-4.58
Tax %27.10%32.96%32.17%21.79%201.64%78.43%41.57%-8.09%-9.09%-21.70%-1.97%-1.54%-7.86%
Net Profit1.561.210.970.60-0.610.110.52-5.58-6.99-7.12-4.98-5.74-4.23
EPS in Rs1.681.301.040.64-0.600.110.35-5.40-3.82-4.77-3.32-2.60-1.17
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move −6.32% · closed higher next day 0 of last 2
 Q1FY27Q2FY27
Broadcast12 Aug '26◦13 Nov '26◦
Earnings day−7.64%−5.00%
+1 day−5.88%−4.04%
+5 days−4.83%—
+15 days+42.68%—
+30 days+6.56%—
FilingXBRLXBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Sep 2026
50.92%Promoter
Promoters50.92%
FIIs0.08%0.08
DIIs0.00%
Public48.99%0.10
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,884.9036.704,51,5380.85%1,995−10.53%16,199+11.88%20.53%
Divi's Lab.₹11,180.5086.862,96,8070.27%1,127+63.57%3,676+35.40%21.97%
Torrent Pharma.₹4,689.5082.071,78,1800.81%534−10.03%4,979+50.79%15.19%
Laurus Labs₹2,294.6092.691,24,1950.09%436+126.43%2,206+33.44%17.76%
Zydus Lifesci.₹1,200.0026.481,19,9900.08%928−27.96%7,910+29.17%21.14%
Dr Reddy's Labs₹1,390.2041.561,16,3600.58%913−31.35%8,698−1.48%13.04%
Cipla₹1,415.0036.881,14,5180.92%852−35.05%7,404−2.44%15.49%
Natural Capsules₹126.19—1320.00%−4+69.11%51+11.68%−4.58%
Median: 160 Co.₹432.2032.471,9870.08%13+33.73%179+21.23%14.94%

Filings